New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
BioCardia, Inc. (BCDA) vs Jasper Therapeutics, Inc. (JSPR)
- BioCardia, Inc. BCDA 0.79 +2.60%
- Jasper Therapeutics, Inc. JSPR 8.69 −19.16%
BioCardia, Inc. and Jasper Therapeutics, Inc. are both Biotechnology companies. BioCardia, Inc. and Jasper Therapeutics, Inc. are of similar size ($11.9M and $11.7M). Across the 7 metrics below, BioCardia, Inc. leads on 4 and Jasper Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | BCDA | JSPR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (2,010.75%) | — | 0.00% |
| Net margin | (1,999.77%) | — | 0.00% |
| Free cash flow margin | — | — | 0.00% |
| Return on equity | (443.27%) | 244.79% | (51.58%) |
| Return on assets | (166.46%) | (153.74%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack